SI0800399T1 - Kombinirano zdravljenje hiperproliferativnih patologij - Google Patents
Kombinirano zdravljenje hiperproliferativnih patologijInfo
- Publication number
- SI0800399T1 SI0800399T1 SI9630511T SI9630511T SI0800399T1 SI 0800399 T1 SI0800399 T1 SI 0800399T1 SI 9630511 T SI9630511 T SI 9630511T SI 9630511 T SI9630511 T SI 9630511T SI 0800399 T1 SI0800399 T1 SI 0800399T1
- Authority
- SI
- Slovenia
- Prior art keywords
- hyperproliferative diseases
- therapeutical treatment
- combined therapeutical
- combined
- treatment
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000003463 hyperproliferative effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000005754 cellular signaling Effects 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 231100000590 oncogenic Toxicity 0.000 abstract 1
- 230000002246 oncogenic effect Effects 0.000 abstract 1
- 230000037361 pathway Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9500436A FR2729295A1 (fr) | 1995-01-17 | 1995-01-17 | Traitement therapeutique combine des pathologies hyperproliferatives |
| PCT/FR1996/000056 WO1996022101A1 (fr) | 1995-01-17 | 1996-01-12 | Traitement therapeutique combine des pathologies hyperproliferatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0800399T1 true SI0800399T1 (sl) | 2002-12-31 |
Family
ID=9475169
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9630511T SI0800399T1 (sl) | 1995-01-17 | 1996-01-12 | Kombinirano zdravljenje hiperproliferativnih patologij |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US6262032B1 (sl) |
| EP (1) | EP0800399B1 (sl) |
| JP (3) | JP4580469B2 (sl) |
| KR (1) | KR100385266B1 (sl) |
| AT (1) | ATE222109T1 (sl) |
| AU (1) | AU716364B2 (sl) |
| BR (1) | BR9606969A (sl) |
| CA (1) | CA2209771C (sl) |
| CZ (1) | CZ298710B6 (sl) |
| DE (1) | DE69622989T2 (sl) |
| DK (1) | DK0800399T3 (sl) |
| ES (1) | ES2180729T3 (sl) |
| FI (1) | FI119911B (sl) |
| FR (1) | FR2729295A1 (sl) |
| HU (1) | HU229484B1 (sl) |
| MX (1) | MX9704490A (sl) |
| NO (1) | NO325418B1 (sl) |
| PT (1) | PT800399E (sl) |
| SI (1) | SI0800399T1 (sl) |
| SK (1) | SK283989B6 (sl) |
| WO (1) | WO1996022101A1 (sl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030044396A1 (en) * | 1998-04-21 | 2003-03-06 | Elia James P. | Methods for treating diseases and increasing longevity |
| FR2729295A1 (fr) * | 1995-01-17 | 1996-07-19 | Rhone Poulenc Rorer Sa | Traitement therapeutique combine des pathologies hyperproliferatives |
| US7087582B1 (en) | 1995-09-26 | 2006-08-08 | Regents Of The University Of Michigan | Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21 |
| US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
| US20030064949A1 (en) * | 1998-02-17 | 2003-04-03 | Loretta Nielsen | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| US20030060434A1 (en) * | 1997-02-18 | 2003-03-27 | Loretta Nielsen | Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| JP4458746B2 (ja) | 2001-01-16 | 2010-04-28 | グラクソ グループ リミテッド | 癌の治療方法 |
| JP4887143B2 (ja) * | 2003-06-30 | 2012-02-29 | ユニベルシテ ド ローザンヌ | 癌細胞を選択的に死滅させるＲａｓＧＡＰ由来ペプチド |
| KR100809890B1 (ko) * | 2003-12-24 | 2008-03-06 | 가부시키가이샤 로코모젠 | 암 억제 방법 |
| WO2005061007A1 (ja) * | 2003-12-24 | 2005-07-07 | St. Marianna University School Of Medicine | 癌の抑制方法 |
| GB0406415D0 (en) * | 2004-03-22 | 2004-04-21 | Inst Of Cancer Res The | Materials and methods for treatment of cancer |
| US8124598B2 (en) * | 2006-09-14 | 2012-02-28 | Sharon Sageman | 7-keto DHEA for psychiatric use |
| US20100111874A1 (en) * | 2007-03-19 | 2010-05-06 | University Of Medicine And Dentistry Of New Jresey | Method of cancer detection and treatment |
| US20100160274A1 (en) * | 2007-09-07 | 2010-06-24 | Sharon Sageman | 7-KETO DHEA for Psychiatric Use |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU614489B2 (en) * | 1986-03-28 | 1991-09-05 | Board Of Trustees Of The University Of Illinois, The | Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| US6410010B1 (en) | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| EP0641193A4 (en) * | 1992-05-20 | 1995-09-06 | Daniel S Martin | CHEMOTHERAPEUTIC DRUG COMBINATIONS. |
| ATE195869T1 (de) * | 1992-05-28 | 2000-09-15 | Xenova Ltd | Acridin carboxamide zur behandlung von krebs |
| FR2694296B1 (fr) * | 1992-07-30 | 1994-09-02 | Rhone Poulenc Rorer Sa | Peptides inhibant l'activité des protéines ras, préparation et utilisation. |
| EP0672137A1 (en) * | 1992-09-18 | 1995-09-20 | CANJI, Inc. | Gene therapy by retroviral vector with tumor suppressive gene |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| TW442569B (en) | 1993-10-25 | 2001-06-23 | Canji Inc | Recombinant adenoviral vector |
| FR2729295A1 (fr) * | 1995-01-17 | 1996-07-19 | Rhone Poulenc Rorer Sa | Traitement therapeutique combine des pathologies hyperproliferatives |
| US5789244A (en) | 1996-01-08 | 1998-08-04 | Canji, Inc. | Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems |
| US6054467A (en) | 1996-07-05 | 2000-04-25 | Sidney Kimmel Cancer Center | Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosis |
-
1995
- 1995-01-17 FR FR9500436A patent/FR2729295A1/fr active Granted
-
1996
- 1996-01-12 MX MX9704490A patent/MX9704490A/es unknown
- 1996-01-12 EP EP96901387A patent/EP0800399B1/fr not_active Expired - Lifetime
- 1996-01-12 SK SK957-97A patent/SK283989B6/sk not_active IP Right Cessation
- 1996-01-12 BR BR9606969A patent/BR9606969A/pt not_active Application Discontinuation
- 1996-01-12 CA CA2209771A patent/CA2209771C/fr not_active Expired - Lifetime
- 1996-01-12 PT PT96901387T patent/PT800399E/pt unknown
- 1996-01-12 AT AT96901387T patent/ATE222109T1/de not_active IP Right Cessation
- 1996-01-12 SI SI9630511T patent/SI0800399T1/sl unknown
- 1996-01-12 DK DK96901387T patent/DK0800399T3/da active
- 1996-01-12 JP JP52207896A patent/JP4580469B2/ja not_active Expired - Lifetime
- 1996-01-12 KR KR1019970704839A patent/KR100385266B1/ko not_active IP Right Cessation
- 1996-01-12 WO PCT/FR1996/000056 patent/WO1996022101A1/fr active IP Right Grant
- 1996-01-12 CZ CZ0226297A patent/CZ298710B6/cs not_active IP Right Cessation
- 1996-01-12 AU AU45429/96A patent/AU716364B2/en not_active Expired
- 1996-01-12 ES ES96901387T patent/ES2180729T3/es not_active Expired - Lifetime
- 1996-01-12 US US08/875,222 patent/US6262032B1/en not_active Expired - Lifetime
- 1996-01-12 DE DE69622989T patent/DE69622989T2/de not_active Expired - Lifetime
- 1996-01-12 HU HU9802423A patent/HU229484B1/hu unknown
-
1997
- 1997-07-09 NO NO19973197A patent/NO325418B1/no not_active IP Right Cessation
- 1997-07-16 FI FI973023A patent/FI119911B/fi not_active IP Right Cessation
-
2001
- 2001-03-26 US US09/816,144 patent/US20010021395A1/en not_active Abandoned
-
2003
- 2003-04-14 US US10/412,684 patent/US7884082B2/en not_active Expired - Fee Related
-
2008
- 2008-01-09 JP JP2008001848A patent/JP2008133291A/ja not_active Withdrawn
-
2011
- 2011-09-22 JP JP2011206858A patent/JP5031921B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI0800399T1 (sl) | Kombinirano zdravljenje hiperproliferativnih patologij | |
| NO20101190L (no) | Anvendelse av buprenorfin i fremstillingen av et medikament | |
| ZA95679B (en) | Products containing G-CSF and TNF binding protein | |
| UA32457C2 (uk) | Лікарський засіб (варіанти) і спосіб медикаментозного впливу на організм | |
| ZA968905B (en) | Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction | |
| HUP9900147A2 (hu) | Terápiás szerek és autoimmun betegségek kezelésére alkalmas gyógyszerkészítmények | |
| PL336760A1 (en) | Treatment of skin diseases | |
| ZA96314B (en) | Use of sertraline to treat cancer patients | |
| EP0835662A3 (en) | A drug for the treatment of cancer | |
| WO2000006696A3 (en) | Method for the modulation of function of transcription factors | |
| IL126158A0 (en) | Method for treating substance abuse | |
| CA2197139A1 (en) | A drug for the treatment of cancer | |
| UA22223A (uk) | Спосіб лікуваhhя захворюваhь оргаhа зору | |
| ZA936136B (en) | Treatment of skin diseases | |
| GEP19991781B (en) | Means for Treatment of Prostate Diseases | |
| HU9500304V0 (en) | Therapeutic aid for treatment of foot | |
| UA28644A (uk) | Спосіб лікування первинної аменореї центрального генезу у дівчат-підлітків | |
| MX9603833A (es) | Tratamiento mejorado del cancer con temozolomida. | |
| ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
| WO2000033823A3 (en) | Methods of using temozolomide in the treatment of cancers | |
| UA30329A (uk) | Спосіб лікування хронічних запальних захворювань придатків матки | |
| MX9709866A (es) | Metodo para el tratamiento de enfermedades de pulmon utilizando oligonucleotidos antisentido. | |
| BG98001U (en) | Medicament for the treatment of hyperkeratotic conditions of the skin | |
| SI0859595T1 (sl) | Terapevtski pripravek za transdermalno aplikacijo aktivnih snovi skozi kožo | |
| GB9520494D0 (en) | Treatment of medical conditions |